Arbutus Biopharma (ABUS) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to $352000.0.
- Arbutus Biopharma's Accumulated Depreciation & Amortization fell 6638.01% to $352000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $352000.0, marking a year-over-year decrease of 6638.01%. This contributed to the annual value of $13.0 million for FY2024, which is 921.01% up from last year.
- As of Q3 2025, Arbutus Biopharma's Accumulated Depreciation & Amortization stood at $352000.0, which was down 6638.01% from $341000.0 recorded in Q2 2025.
- Over the past 5 years, Arbutus Biopharma's Accumulated Depreciation & Amortization peaked at $13.0 million during Q4 2024, and registered a low of $330000.0 during Q1 2025.
- For the 5-year period, Arbutus Biopharma's Accumulated Depreciation & Amortization averaged around $2.9 million, with its median value being $777000.0 (2022).
- As far as peak fluctuations go, Arbutus Biopharma's Accumulated Depreciation & Amortization surged by 2300.22% in 2021, and later crashed by 6638.01% in 2025.
- Arbutus Biopharma's Accumulated Depreciation & Amortization (Quarter) stood at $9.4 million in 2021, then rose by 15.22% to $10.8 million in 2022, then increased by 10.17% to $11.9 million in 2023, then rose by 9.21% to $13.0 million in 2024, then crashed by 97.29% to $352000.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $352000.0 for Q3 2025, versus $341000.0 for Q2 2025 and $330000.0 for Q1 2025.